Health

Scrapped Covid vaccine deal with Valneva cost UK taxpayers £358m


A spokesman for Valneva said the firm was “exploring options for its Almeida manufacturing facility in Livingston, initially built to produce its Covid-19 vaccine, including a possible sale or a repurposing to produce its vaccine for Japanese Encephalitis, and its chikungunya vaccine, if approved”.



READ SOURCE

Readers Also Like:  Salmonella outbreak linked to cantaloupes sickens more than 40 people and hospitalizes 17 in US

This website uses cookies. By continuing to use this site, you accept our use of cookies.